Guest Open Access | Free Content | About | Sign in | New Users: Sign up | Mark List  
  Current Pharmaceutical Design
ISSN: 1381-6128
 
  < Previous Issue | Next Issue > | All Issues   |   All Titles
 
Volume 16
  Issue 3
          Articles
  Editorial [Hot topic: New Generation Cancer Vaccines: From Tumor Immunology to Clinical Applications (Executive Editor: Simone Mocellin)]
    pp.253-254 (2) Author: Simone Mocellin
   
  Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
    pp.255-267 (13) Authors: Norberto W. Zwirner, Diego O. Croci, Carolina I. Domaica, Gabriel A. Rabinovich
   
  Circumventing Immune Tolerance Through Epigenetic Modification
    pp.268-276 (9) Authors: Jason A. Dubovsky, Alejandro Villagra, John J. Powers, Hong-Wei Wang, Javier Pinilla-Ibarz, Eduardo M. Sotomayor
   
  Metabolic Immune Restraints: Implications for Anticancer Vaccines
    pp.277-291 (15) Author: Simone Mocellin
   
  Cancer Vaccines: Emphasis on Pediatric Cancers
    pp.292-299 (8) Authors: Terri Guinipero, Olivera J. Finn
   
  Idiotype Vaccines for Human B-Cell Malignancies
    pp.300-307 (8) Authors: S. Inoges, A. Lopez-Diaz de Cerio, E. Soria, H. Villanueva, F. Pastor, M. Bendandi
   
  Editorial [Hot topic: The Search of Targets for Novel Antipsychotic Drugs (Executive Editor: Akihiro Takano)]
    pp.308-308 (1) Author: Akihir Takano
   
  Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
    pp.309-322 (14) Authors: Richard J. Radek, Kathy L. Kohlhaas, Lynne E. Rueter, Eric G. Mohler
   
  Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
    pp.323-343 (21) Authors: Morten S. Thomsen, Henrik H. Hansen, Mikkelsen B. Timmerman, Jens D. Mikkelsen
   
  Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia
    pp.344-357 (14) Authors: Lee A. Dawson, Paul W. Smith
   
  Conditioned Avoidance Response in the Development of New Antipsychotics
    pp.358-370 (13) Author: M-L. G. Wadenberg
   
  The Application of PET Technique for the Development and Evaluation of Novel Antipsychotics
    pp.371-377 (7) Author: Akihiro Takano
   
  Key: New Content Free Content Open Access Subscribed Content


Bentham Science Publishers
www.bentham.org